These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23331007)
1. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways. Liu J; Albrecht AM; Ni X; Yang J; Li M Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007 [TBL] [Abstract][Full Text] [Related]
2. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Wang G; Wang JJ; Tang HM; To SS Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679 [TBL] [Abstract][Full Text] [Related]
4. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related]
5. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview. Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968 [TBL] [Abstract][Full Text] [Related]
6. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy. Wang G; Wang J; Zhao H; Wang J; Tony To SS Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775 [TBL] [Abstract][Full Text] [Related]
7. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility. Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694 [TBL] [Abstract][Full Text] [Related]
8. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways. Jhanwar-Uniyal M; Albert L; McKenna E; Karsy M; Rajdev P; Braun A; Murali R Adv Enzyme Regul; 2011; 51(1):164-70. PubMed ID: 21035497 [TBL] [Abstract][Full Text] [Related]
10. Necroptosis: a novel therapeutic target for glioblastoma. Jiang YG; Peng Y; Koussougbo KS Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544 [TBL] [Abstract][Full Text] [Related]
11. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme. Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157 [TBL] [Abstract][Full Text] [Related]
13. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236 [TBL] [Abstract][Full Text] [Related]
14. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698 [TBL] [Abstract][Full Text] [Related]
15. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells. Deng Y; Zhu G; Luo H; Zhao S Mol Cells; 2016 Aug; 39(8):619-24. PubMed ID: 27484906 [TBL] [Abstract][Full Text] [Related]
18. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378 [TBL] [Abstract][Full Text] [Related]
19. Targeting apoptosis pathways in glioblastoma. Eisele G; Weller M Cancer Lett; 2013 May; 332(2):335-45. PubMed ID: 21269762 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs involved in the EGFR pathway in glioblastoma. Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]